All Stories

Sanofi nets €10B from Opella stake sale, eyes more 'bolt-on' deals

Six months after entering talks with U.S. private equity firm Clayton, Dubilier & Rice, Sanofi has closed a deal to sell a 50% controlling stake of its consumer health business Opella for 10 billion euros ($11.4 billion).

Apr 30, 2025 - 17:11
 0
Sanofi nets €10B from Opella stake sale, eyes more 'bolt-on' deals
Six months after entering talks with U.S. private equity firm Clayton, Dubilier & Rice, Sanofi has closed a deal to sell a 50% controlling stake of its consumer health business Opella for 10 billion euros ($11.4 billion).
Read More

Tags:

Previous Article

More automakers scrap their 2025 guidance due to tariff chaos

Next Article

More Good Electric 2- & 3-Wheeler News From East & West Africa

Related Posts

Galderma, seeking to build $2B product, starts DTC campaign for eczema drug across TV, digital

Galderma, seeking to build $2B product, starts DTC camp...

Apr 22, 2025  0

Halozyme sues Merck over subcutaneous Keytruda as licensing talks fall through

Halozyme sues Merck over subcutaneous Keytruda as licen...

Apr 24, 2025  0

Top leaders at FDA marketing overseer resign, potentially teeing up RFK Jr.’s promised drug-ad ban: report

Top leaders at FDA marketing overseer resign, potential...

Apr 21, 2025  0